Indraprastha Medical (BOM:532150) Research & Development: ₹0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532150 Indraprastha Medical Corp Ltd BOM:532150
81 GF Score
Price ₹376.95
GF Value ₹420.21
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Indraprastha Medical Research & Development?

Indraprastha Medical BOM:532150 -1.95% 81 Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus rates BOM:532150 with a GF Score™ of 81/100 and a GF Value™ of ₹420.21 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Indraprastha Medical's Research & Development for the three months ended in Mar. 2026 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil.

Indraprastha Medical  (BOM:532150) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Indraprastha Medical Research & Development Related Terms

Indraprastha Medical Research & Development Historical Data

* Premium members only.

The historical data trend for Indraprastha Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indraprastha Medical Research & Development Chart

Indraprastha Medical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Indraprastha Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:532150
81GF Score
Indraprastha Medical Corp Ltd BOM:532150
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indraprastha Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Indraprastha Medical (BOM:532150) has a Research & Development of ₹0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Indraprastha Medical and its competitors.
Is Indraprastha Medical's Research & Development too high?
Indraprastha Medical's current Research & Development is ₹0 Mil. Overall, Indraprastha Medical has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Indraprastha Medical's Research & Development compare to HCA and THC?
Indraprastha Medical's Research & Development of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Indraprastha Medical and its competitors. Indraprastha Medical's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indraprastha Medical stock overvalued right now?
Based on GuruFocus' analysis, Indraprastha Medical (BOM:532150) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹420.21, compared to a current price of ₹376.95 — trading 10.3% below its estimated fair value. The current Research & Development is ₹0 Mil. Indraprastha Medical's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Indraprastha Medical (BOM:532150), the current Research & Development is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Indraprastha Medical (BOM:532150) Overvalued in 2026?

Based on GuruFocus' analysis, Indraprastha Medical stock appears to be undervalued. The current stock price of ₹376.95 is trading 10.3% below its estimated GF Value™ of ₹420.21. GuruFocus considers Indraprastha Medical to be Modestly Undervalued.

Key valuation signals for BOM:532150:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹420.21 vs. price of ₹376.95 (10.3% below fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the BOM:532150 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Indraprastha Medical Business Description

Other Exchanges INDRAMEDCO:India
Address Delhi-Mathura Road, Sarita Vihar, New Delhi, IND, 110 076
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.
81GF Score

Get the complete analysis for BOM:532150

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹376.95
Price
₹420.21
GF Value